Legionella infection is an important cause of community-acquired pneumonia in Australia. Morbidity and mortality is significant. Diagnosis remains a challenge with infection often unrecognised, particularly early in the course of illness. An understanding of available diagnostic methods and their limitations is important to public health practitioners and clinicians alike.
Microbiology and clinical spectrum
Legionella spp. are ubiquitous environmental Gramnegative bacteria. They are able to survive in moist environments for long periods of time and grow well at temperatures ranging from 20 to 42°C. 5 They have an increased tolerance to chlorine and thus enter watersupply systems and proliferate in thermal habitats, including air-conditioning towers, hot water systems, shower heads, taps, spas and respiratory ventilators. 6 There are currently more than 50 species described, including at least 16 serogroups of L. pneumophila. 5 Infections range from a severe multisystem disease including pneumonia to an asymptomatic infection. 1, 5, 7 Pneumonia due to L. pneumophila is termed Legionnaires' disease. Worldwide, L. pneumophila serogroup 1 is the most common cause of Legionnaires' disease. Pneumonia can be caused by other Legionella spp.; L. longbeachae, L. bozemanii, L. dumoffii and L. micdadei are the most frequently described. 1, 2, 5, 8, 9 Pontiac fever, a self-limiting nonpneumonic febrile illness, is also described.
In the period 1991-2000 in Australia, L. pneumophila was responsible for 51% of cases of clinical disease, with L. pneumophila serogroup 1 the most frequently reported pathogen. 10 L. longbeachae is another frequent pathogen in Australia, responsible for 42% of the total number of cases. 10 
Laboratory diagnosis from clinical specimens
It is not possible to distinguish patients with Legionnaires' disease from other forms of pneumonia by clinical or radiological means. 11, 12 As a result, laboratory confirmation is essential for diagnosis. Although diagnostic methods have improved, no currently available test is able to diagnose all Legionella infections in a timely fashion, with a high degree of sensitivity and specificity. The available methods are summarised in Table 1. Definitive legionellosis is defined by the Public Health Laboratory Network as isolation of Legionella spp., detection of Legionella antigen in urine, seroconversion or significant increase in serum Legionella antibody levels. 13 Suggestive legionellosis is defined as detection of Legionella antigen by direct fluorescent antigen (DFA), detection of Legionella DNA by polymerase chain reaction (PCR), or a single high antibody level to L. pneumophila or L. longbeachae. 13 These laboratory definitions are used in combination with clinical parameters to identify, for public health purposes, confirmed and probable cases of Legionella infection. 14 Culture Isolation of Legionella spp. by culture is considered the 'gold standard' for diagnosis because of its superior specificity. Legionella spp. are most frequently isolated from respiratory tract specimens (e.g. sputa, bronchoalveolar lavage (BAL), lung). Lung biopsy specimens have the greatest yield but are rarely performed. 5 Bronchoscopic samples have a greater diagnostic yield compared with expectorated sputum samples. 15 In most laboratories, polyvalent or monoclonal antisera are used to identify presumptive L. pneumophila and L. longbeachae. 13 These techniques are unreliable for other species, owing to a high degree of cross-reactivity between different species with molecular techniques preferred.
The major advantage of culture for diagnosis is that all Legionella spp. are able to be detected by this method. A culture isolate is also required for further epidemiological typing or for susceptibility testing.
There are, however, inherent problems with Legionella culture because the organism is fastidious and slow growing (often taking 5 days or more to grow). 13 Specifically formulated media (most frequently buffered charcoal yeast-extract media) are required to enhance the growth of Legionella spp. and suppress other respiratory bacteria.
Patients with Legionnaires' disease are often nonproductive of sputum and therefore require invasive procedures to obtain respiratory samples (e.g. BAL fluid). The yield from culture depends on the severity of the illness: 15-25% of mild pneumonia cases are culture positive compared with 95% in cases of severe pneumonia causing respiratory failure. 15 Delays in sputa processing and prior specific antimicrobial therapy decrease the yield. 5 Fluorescent microscopy Direct fluorescent-antibody (DFA) staining is a rapid method of directly detecting Legionella spp. in respiratory secretions and tissue samples. Although rapid, it is insensitive, requiring large organism numbers for visualisation (i.e. severe disease). Reported sensitivity of fluorescent microscopy varies but is consistently less than that of culture. 15 Furthermore, it is technically demanding, requiring experienced laboratory personnel. False positive results may occur because of cross-reactions with other bacteria and yeasts. 5 Problems with both sensitivity and specificity have limited the use of DFA staining in most laboratories. for species other than L. pneumophila serogroup 1). 19 In particular, no commercial assay is available to reliably detect L. longbeachae in urine.
Polymerase chain reaction PCR-based detection of Legionella DNA in sputum, urine and blood has been described. 1, 6, 15 PCR amplifies minute amounts of Legionella DNA, providing results within a short time and enabling detection of infection caused by all Legionella species and serogroups. Molecular methods can be formulated to incorporate real-time or multiplex formats. Despite the availability of commercial assays (e.g. Chlamylege kit, Argene Inc, NY), Legionella PCR is available only in a limited number of laboratories in Australia.
When testing clinical samples from the lower respiratory tract, PCR has been shown to have sensitivity equal to or greater than culture. [20] [21] [22] False positive results have been reported using both in-house and commercial assays. 6 Legionella DNA can also be detected from other samples, but with reduced sensitivity (30-86%). 15 
Serology
Serological testing for Legionella infection is a valuable epidemiological tool but is of less immediate benefit to physicians because of delayed seroconversion. Indirect immunofluorescent assays (IFA) and enzyme-linked immunosorbent assays (ELISA or EIA) are the most frequently performed tests. 13 13 The demonstration of seroconversion or a four-fold rise in titre on a convalescent sample is required for diagnosis of definitive Legionella infection. In most cases, seroconversion is detected within 3-4 weeks; however, up to 10 weeks has been reported. 23 A proportion of people with a proven Legionella infection do not develop detectable Legionella antibodies. 15 Crossreactive antibodies are occasionally found in patients with other infections or non-infectious conditions. Clinicians should be encouraged to obtain convalescent samples after a minimum of 3 weeks. If there is no seroconversion after this time and clinical suspicion remains high, an additional convalescent sample should be obtained. IgM measured by ELISA can become positive earlier in the course of illness compared with IFA, although it may remain elevated for years and numerous cross-reactions can occur. 13 Identification of Legionella spp. from environmental specimens Attempts to culture Legionella spp. from environmental sources may be undertaken to investigate a clinical case cluster or as a part of the regular surveillance. An environmental investigation is generally not required following individual cases; however, the decision to investigate should be made by individual public health units, taking local factors into consideration. 14 A number of tools, including electronic maps of registered cooling towers, may be utilised to identify potential point sources (Vicky Sheppeard, pers. comm.).
A number of NATA-registered laboratories process environmental samples for Legionella. Culture methods are similar to those used in clinical laboratories. Following heat treatment to reduce growth of other bacteria, an aliquot of water is incubated on selective media. Following growth of suspicious colonies, antisera are used to identify presumptive L. pneumophila. 
Typing of Legionella isolates

Conclusion
Well-established methods such as culture for Legionella and urinary Legionella antigen detection remain the mainstay of diagnosis of Legionella infections. Newer methods, including PCR-based assays, are likely to become more widely available in the future. Given the current limitations of laboratory diagnosis, patients presenting with pneumonia will continue to receive empiric therapy against Legionella.
